drugset / Trial / NCT02072083

Intranasal Dexmedetomidine vs Midazolam-ketamine Combination for Premedication of Pediatric Patients

NCT02072083 ↗

Phase 4 Completed 60 enrolled TC Erciyes University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of this study is using intranasal dexmedetomidine versus intranasal midazolam-ketamine combination for premedication and preventing the oculocardiac reflex of pediatric patients undergoing strabismus surgery.

Timeline

Start
2014-02
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intranasal
Comparator Ketamine Small molecule 7.5 mg/kg Intranasal
Comparator Midazolam Small molecule 0.1 mg/kg Intranasal

Indications

No indication recorded.